Eisai Co., Ltd.

Yield per half year: +11.29%
Dividend yield: 3.56%
Sector: Healthcare

Eisai Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
27.98 80.24 -65.12% 31.31 -10.63%
P/S 1.65 84.4 -98.05%
P/BV 1.54 69.6 -97.78%
P/FCF 71.46 -13.81 -617.31%
Ev/Ebitda 10.5 98.32 -89.32%
Ev/S 1.39 82.55 -98.32%
Ev/FCF 60.34 -56.9 -206.04%
E/P 0.0357 0.0287 24.38%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
13.24 -190.22 -106.96% 13.07 +1.3%
ROE 5.52 -9.63 -157.3%
ROA 3.35 0.5791 478.23%
ROIC 8.5 8.03 5.84%
ROS 5.88 -224.84 -102.62%
ROCE 7.46 -7.4 -200.81%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
7/10
1.79 6.46 -72.24% 1.38 +30.21%
Nеt Debt/Ebitda -0.7468 -53.72 -98.61%
Debt/Ratio 0.1352 0.1493 -9.41%
Debt/Equity 0.6011 1.09 -44.73%
Debt/Net Income 4.04 5.88 -31.36%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
8.9/10
3.56 1.82 95.81% 2.79 +27.66%
Number of years of dividend growth 0 1.79 -100%
DSI 0.8571 0.7147 19.93%
Average dividend growth -8.33 -111.88 -92.55%
Average percentage for 5 years 2.79 16.98 -83.57%
Average percentage for payments 85.59 43.74 95.69%
Difference from average difference in sector 1.74

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
22.21 249.13 -91.08%
Growth impulse Ebitda in 5 years 15.83 384.71 -95.89%
Growth impulse Net Income in 5 years 10.24 248.33 -95.88%
Growth impulse FCF in 5 years -49.08 303.27 -116.18%
Growth impulse EPS in 5 years -72.13 182.9 -139.44%
IP Score
4.9/10

Similar companies

Takeda Pharmaceutical Company Limited

Daiichi Sankyo Company, Limited

HOYA Corporation

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription